A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole

J Infect. 2005 Oct;51(3):e177-80. doi: 10.1016/j.jinf.2005.01.001.

Abstract

A 79-year-old man with a 3-month history of weight loss and fever was diagnosed with disseminated histoplasmosis. When the infection became refractory to itraconazole therapy, posaconazole was prescribed. The patient became asymptomatic within 1 month of beginning treatment, and his general health improved. Posaconazole was discontinued after 6 months, and the patient has remained well since.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / therapeutic use*
  • Drugs, Investigational / therapeutic use*
  • Histoplasma / drug effects
  • Histoplasmosis / drug therapy*
  • Histoplasmosis / microbiology
  • Humans
  • Male
  • Treatment Outcome
  • Triazoles / therapeutic use*

Substances

  • Antifungal Agents
  • Drugs, Investigational
  • Triazoles
  • posaconazole